The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Colombia is a mid-sized pharmaceutical market in Latin America (ranking fourth in terms of sales volume in 2017, after Brazil, Mexico and Argentina), with a large and growing population, a universal but underfunded social security health insurance ...READ MORE
The Pharmaceuticals & Healthcare sector in the Philippines is in a phase of accelerating growth as strong economic performance in the country has been making healthcare more accessible to Filipinos. Additionally, the Philippines government has ...READ MORE
Demand for the products and services of the Pharmaceuticals & Healthcare sector has been growing strongly in Thailand over the past few years. Thailand has one of the most rapidly aging societies in Asia. The country’s rising affluence has ...READ MORE
In the second quarter of 2018, China’s pharmaceutical and medicine production declined by 21.1% y/y to 749,000 tonnes, while their sales volume dropped by 22.7% y/y to 753,000 tonnes. This can be linked with the more stringent environmental ...READ MORE
The second quarter of 2018 witnessed a continuous growth of China’s healthcare sector. The growth was attributed to increasing demand for quality healthcare, stimulated by the country’s strong economic performance, rising incomes, ...READ MORE
Demand in the Malaysian Pharmaceuticals & Healthcare sector has been growing rapidly over the last few years as Malaysians have become more affluent and demanding with their healthcare needs. The aging population has also been seeing higher ...READ MORE
The first quarter of 2018 witnessed a continuous growth of China’s healthcare sector, stimulated by government policies and regulations. The country’s total spending on health and family planning reached RMB 442.6bn, up by 7.8% ...READ MORE
In Q4 2017, the government expenditure on health and family planning was RMB 276.7bn, representing a decrease of 7.5% y/y. Nevertheless, the healthcare expenditure in urban area was RMB 453.9bn, up by 2.8% y/y. For the whole year 2017, the government ...READ MORE
China is the world’s second largest pharmaceutical market after the US and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large share of ageing ...READ MORE
Argentina is among the top 20 pharmaceutical markets globally, ranking third in Latin America, with estimated drug retail sales of USD 6.1bn in 2017. The country also features a large and ageing population, a relatively developed public health system ...READ MORE